Results 91 to 100 of about 932,015 (310)

Hobby Lobby and the Pathology of Citizens United [PDF]

open access: yes, 2014
Four years ago, Citizens United v. Federal Election Commission held that for-profit corporations possess a First Amendment right to make independent campaign expenditures.
Katz, Ellen D.
core   +2 more sources

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende   +26 more
wiley   +1 more source

Ontological approach to the normative dimension of organizations: an application of Documents Acts Ontology

open access: yesCiência da Informação, 2017
Modeling and knowledge representation are indispensable activities for developing information systems in the scope of modern corporations. In order to accomplish these activities, one should analyze a corporation both in terms of its physical structure ...
Maurício Barcellos Almeida   +3 more
doaj  

Towards dealing with multinationals [PDF]

open access: yes, 2018
Paper on dealing with multinational corporations as a key strategy for escaping Africa's ...
Seidman, Ann
core  

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher   +10 more
wiley   +1 more source

MODELING OF CORPORATE STRUCTURES OF INDUSTRIAL ENTERPRISES

open access: yesВестник Дагестанского государственного технического университета: Технические науки, 2016
This article was first based on the use of complex mathematical models of dynamic programming analyzed the problem of optimizing the distribution of internal investment.As a result of research by the author for the first time demonstrated the model to ...
D. S. Таgaverdieva
doaj   +1 more source

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li   +10 more
wiley   +1 more source

Are hostile takeovers different? [PDF]

open access: yes
Consolidation and merger of corporations ; Corporations ...
Eric S. Rosengren, Lynn E. Browne
core  

The Web 2.0 as Marketing Tool: Opportunities for SMEs [PDF]

open access: yes, 2008
The new generation of Internet applications widely known as Social Media or Web 2.0 offers corporations a whole range of opportunities for improving their marketing efficiency and internal operations.
Constantinides, Efthymios
core   +3 more sources

Clinical Validation of Plasma p‐217tau in Neurological Diseases

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy